Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT05643742Phase 1/2Recruiting
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
B-cell LymphomaB-cell MalignancyChronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)+5 more
StudydirectorStart date: 2023-03-10

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Lymphoma, B-CellLarge B-cell LymphomaMarginal Zone Lymphoma
Similarity Score11%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Lymphoma, FollicularLymphoma, B-CellLymphoma, Non-Hodgkin
Similarity Score11%

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

Related
2 trials

Shared therapeutic areas:

Lymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score8%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

Related
2 trials

Shared therapeutic areas:

Lymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score8%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Lymphoma, FollicularMarginal Zone Lymphoma
Similarity Score8%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLymphoma, B-Cell
Similarity Score8%

Carlos Montalbán Sanz, MD

Hospital Universitario Ramon y Cajal

Related
2 trials

Shared therapeutic areas:

Lymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score8%

Eulogio Conde García, MD

Hospital Marqués de Valdecilla

Related
2 trials

Shared therapeutic areas:

Lymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score8%

David Cunningham

Royal Marsden NHS Foundation Trust

Related
13 trials

Shared therapeutic areas:

Lymphoma, B-CellLymphoma, Non-Hodgkin
Similarity Score8%

Weidong Han, Ph.D

Biotherapeutic Department, Chinese PLA General Hospital

Related
12 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLymphoma, B-Cell
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05643742Phase 1/2StudyDirector

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

B-cell LymphomaB-cell MalignancyChronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)+5 more
Recruiting

All 1 trials loaded